The DOI matches its Crossref record; 152 of the 152 references it cites were found in a registry or an index.
Role of Merlin/NF2 inactivation in tumor biology
Open accessAbstract
Merlin (Moesin-ezrin-radixin-like protein, also known as schwannomin) is a tumor suppressor protein encoded by the neurofibromatosis type 2 gene NF2. Loss of function mutations or deletions in NF2 cause neurofibromatosis type 2 (NF2), a multiple tumor forming disease of the nervous system. NF2 is characterized by the development of bilateral vestibular schwannomas. Patients with NF2 can also develop schwannomas on other cranial and peripheral nerves, as well as meningiomas and ependymomas. The only potential treatment is surgery/radiosurgery, which often results in loss of function of the involved nerve. There is an urgent need for chemotherapies that slow or eliminate tumors and prevent their formation in NF2 patients. Interestingly NF2 mutations and merlin inactivation also occur in spontaneous schwannomas and meningiomas, as well as other types of cancer including mesothelioma, glioma multiforme, breast, colorectal, skin, clear cell renal cell carcinoma, hepatic and prostate cancer. Except for malignant mesotheliomas, the role of NF2 mutation or inactivation has not received much attention in cancer, and NF2 might be relevant for prognosis and future chemotherapeutic approaches. This review discusses the influence of merlin loss of function in NF2-related tumors and common human cancers. We also discuss the NF2 gene status and merlin signaling pathways affected in the different tumor types and the molecular mechanisms that lead to tumorigenesis, progression and pharmacological resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
Sjöblom, T., Jones, S., Wood, L. D., Parsons, D. W., Lin, J., Barber, T. D., Mandelker, D., Leary, R. J., Ptak, J., Silliman, N., et al. (2006) · Science · doi:10.1126/science.1133427 · Cited by 3,169
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M.-K., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,192
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,928
The Biology of YAP/TAZ: Hippo Signaling and Beyond
Piccolo, S., Dupont, S., & Cordenonsi, M. (2014) · Physiological Reviews · doi:10.1152/physrev.00005.2014 · Cited by 1,802
"Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells
Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., & Melton, D. A. (2002) · Science · doi:10.1126/science.1072530 · Cited by 1,709
Aragona, M., Panciera, T., Manfrin, A., Giulitti, S., Michielin, F., Elvassore, N., Dupont, S., & Piccolo, S. (2013) · Cell · doi:10.1016/j.cell.2013.07.042 · Cited by 1,651
Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., et al. (1993) · Nature · doi:10.1038/363515a0 · Cited by 1,420
Trofatter, J. (1993) · Cell · doi:10.1016/0092-8674(93)90406-g · Cited by 1,403
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
Esteller, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205600 · Cited by 1,233
Epidemiology and etiology of meningioma
Wiemels, J., Wrensch, M., & Claus, E. B. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0386-3 · Cited by 1,226
The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal
Zhao, B., Tumaneng, K., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2303 · Cited by 1,205
Li, N., Batzer, A., Daly, R., Yajnik, V., Skolnik, E., Chardin, P., Bar-Sagi, D., Margolis, B., & Schlessinger, J. (1993) · Nature · doi:10.1038/363085a0 · Cited by 952
Zhou, D., Conrad, C., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 913
Hippo pathway regulation by cell morphology and stress fibers
Wada, K.-I., Itoga, K., Okano, T., Yonemura, S., & Sasaki, H. (2011) · Development · doi:10.1242/dev.070987 · Cited by 849
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Lu, L., Li, Y., Kim, S. M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G., Finegold, M. J., Lee, J.-S., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911427107 · Cited by 721
Asthagiri, A. R., Parry, D. M., Butman, J. A., Kim, H. J., Tsilou, E. T., Zhuang, Z., & Lonser, R. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60259-2 · Cited by 665
Pearson, M. A., Reczek, D., Bretscher, A., & Karplus, P. A. (2000) · Cell · doi:10.1016/s0092-8674(00)80836-3 · Cited by 604
Cloughesy, T. F., Yoshimoto, K., Nghiemphu, P., Brown, K., Dang, J., Zhu, S., Hsueh, T., Chen, Y., Wang, W., Youngkin, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050008 · Cited by 593
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
Song, H., Mak, K. K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., Simpson, R. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911409107 · Cited by 583
Histological classification and molecular genetics of meningiomas
Riemenschneider, M. J., Perry, A., & Reifenberger, G. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70625-1 · Cited by 573
Comparative biology of mouse versus human cells: modelling human cancer in mice
Rangarajan, A., & Weinberg, R. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1235 · Cited by 567
Morrison, H., Sherman, L. S., Legg, J., Banine, F., Isacke, C., Haipek, C. A., Gutmann, D. H., Ponta, H., & Herrlich, P. (2001) · Genes & Development · doi:10.1101/gad.189601 · Cited by 536
Yin, F., Yu, J., Zheng, Y., Chen, Q., Zhang, N., & Pan, D. (2013) · Cell · doi:10.1016/j.cell.2013.08.025 · Cited by 504
YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth
Low, B. C., Pan, C. Q., Shivashankar, G. V., Bershadsky, A., Sudol, M., & Sheetz, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.012 · Cited by 412
McClatchey, A. I., Saotome, I., Mercer, K., Crowley, D., Gusella, J. F., Bronson, R. T., & Jacks, T. (1998) · Genes & Development · doi:10.1101/gad.12.8.1121 · Cited by 388
Giovannini, M., Robanus-Maandag, E., van der Valk, M., Niwa-Kawakita, M., Abramowski, V., Goutebroze, L., Woodruff, J. M., Berns, A., & Thomas, G. (2000) · Genes & Development · doi:10.1101/gad.14.13.1617 · Cited by 369
Contact-dependent inhibition of EGFR signaling by Nf2/Merlin
Curto, M., Cole, B. K., Lallemand, D., Liu, C.-H., & McClatchey, A. I. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200703010 · Cited by 363
The Nf2 Tumor Suppressor, Merlin, Functions in Rac-Dependent Signaling
Shaw, R. J., Paez, J. G., Curto, M., Yaktine, A., Pruitt, W. M., Saotome, I., O'Bryan, J. P., Gupta, V., Ratner, N., Der, C. J., et al. (2001) · Developmental Cell · doi:10.1016/s1534-5807(01)00009-0 · Cited by 343
NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions
Lallemand, D., Curto, M., Saotome, I., Giovannini, M., & McClatchey, A. I. (2003) · Genes & Development · doi:10.1101/gad.1054603 · Cited by 324
Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the Nucleus
Li, W., You, L., Cooper, J., Schiavon, G., Pepe-Caprio, A., Zhou, L., Ishii, R., Giovannini, M., Hanemann, C. O., Long, S. B., et al. (2010) · Cell · doi:10.1016/j.cell.2010.01.029 · Cited by 321
James, M. F., Han, S., Polizzano, C., Plotkin, S. R., Manning, B. D., Stemmer-Rachamimov, A. O., Gusella, J. F., & Ramesh, V. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01581-08 · Cited by 306
Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer
(1995) · Lung Cancer · doi:10.1016/0169-5002(95)90162-0 · Cited by 296
The Hippo signaling pathway and stem cell biology
Ramos, A., & Camargo, F. D. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2012.04.006 · Cited by 287
Bourguignon, L. Y. W., Zhu, H., Shao, L., & Chen, Y. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1829 · Cited by 283
p21-activated Kinase Links Rac/Cdc42 Signaling to Merlin
Xiao, G.-H., Beeser, A., Chernoff, J., & Testa, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100553200 · Cited by 272
Nf2 /Merlin controls progenitor homeostasis and tumorigenesis in the liver
Benhamouche, S., Curto, M., Saotome, I., Gladden, A. B., Liu, C.-H., Giovannini, M., & McClatchey, A. I. (2010) · Genes & Development · doi:10.1101/gad.1938710 · Cited by 269
LATS2 Is a Tumor Suppressor Gene of Malignant Mesothelioma
Murakami, H., Mizuno, T., Taniguchi, T., Fujii, M., Ishiguro, F., Fukui, T., Akatsuka, S., Horio, Y., Hida, T., Kondo, Y., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2164 · Cited by 263
Yi, C., Troutman, S., Fera, D., Stemmer-Rachamimov, A., Avila, J. L., Christian, N., Persson, N. L., Shimono, A., Speicher, D. W., Marmorstein, R., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.017 · Cited by 260
Kissil, J. L., Wilker, E. W., Johnson, K. C., Eckman, M. S., Yaffe, M. B., & Jacks, T. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00382-4 · Cited by 257
Kissil, J. L., Johnson, K. C., Eckman, M. S., & Jacks, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200083200 · Cited by 254
High Incidence of ActivatingTERTPromoter Mutations in Meningiomas Undergoing Malignant Progression
Goutagny, S., Nault, J. C., Mallet, M., Henin, D., Rossi, J. Z., & Kalamarides, M. (2014) · Brain Pathology · doi:10.1111/bpa.12110 · Cited by 249
Li, W., Cooper, J., Zhou, L., Yang, C., Erdjument-Bromage, H., Zagzag, D., Snuderl, M., Ladanyi, M., Hanemann, C. O., Zhou, P., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.001 · Cited by 243
Chen, C.-S., Weng, S.-C., Tseng, P.-H., Lin, H.-P., & Chen, C.-S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505733200 · Cited by 231
Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types
Bianchi, A. B., Hara, T., Ramesh, V., Gao, J., Klein-Szanto, A. J. P., Morin, F., Menon, A. G., Trofatter, J. A., Gusella, J. F., Seizinger, B. R., et al. (1994) · Nature Genetics · doi:10.1038/ng0294-185 · Cited by 230
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse
Kalamarides, M., Niwa-Kawakita, M., Leblois, H., Abramowski, V., Perricaudet, M., Janin, A., Thomas, G., Gutmann, D. H., & Giovannini, M. (2002) · Genes & Development · doi:10.1101/gad.226302 · Cited by 224
Merlin/Neurofibromatosis Type 2 Suppresses Growth by Inhibiting the Activation of Ras and Rac
Morrison, H., Sperka, T., Manent, J., Giovannini, M., Ponta, H., & Herrlich, P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1608 · Cited by 223
McClatchey, A. I., Saotome, I., Ramesh, V, Gusella, J. F., & Jacks, T. (1997) · Genes & Development · doi:10.1101/gad.11.10.1253 · Cited by 207
Okada, T., Lopez-Lago, M., & Giancotti, F. G. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200503165 · Cited by 195
Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase
Jin, H., Sperka, T., Herrlich, P., & Morrison, H. (2006) · Nature · doi:10.1038/nature04856 · Cited by 193
López-Lago, M. A., Okada, T., Murillo, M. M., Socci, N., & Giancotti, F. G. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01578-08 · Cited by 184
Poulikakos, P. I., Xiao, G.-H., Gallagher, R., Jablonski, S., Jhanwar, S. C., & Testa, J. R. (2006) · Oncogene · doi:10.1038/sj.onc.1209587 · Cited by 178
Striedinger, K., VandenBerg, S. R., Baía, G. S., McDermott, M. W., Gutmann, D. H., & Lal, A. (2008) · Neoplasia · doi:10.1593/neo.08642 · Cited by 173
Stamenkovic, I., & Yu, Q. (2010) · Current Protein & Peptide Science · doi:10.2174/138920310791824011 · Cited by 170
Merlin differentially associates with the microtubule and actin cytoskeleton
Xu, H.-M., & Gutmann, D. H. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980201)51:3<403::aid-jnr13>3.0.co;2-7 · Cited by 170
Sainio, M. A., Zhao, F., Heiska, L., Turunen, O., den Bakker, M., Zwarthoff, E. C., Lutchman, M., Rouleau, G. A., Jääskeläinen, J. E., Vaheri, A. I., et al. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.18.2249 · Cited by 169
Yi, C., Shen, Z., Stemmer-Rachamimov, A., Dawany, N., Troutman, S., Showe, L. C., Liu, Q., Shimono, A., Sudol, M., Holmgren, L., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004060 · Cited by 168
CD44 Acts Both as a Growth‐ and Invasiveness‐Promoting Molecule and as a Tumor‐Suppressing Cofactor
HERRLICH, P., MORRISON, H., SLEEMAN, J., ORIAN‐ROUSSEAU, V., KÖNIG, H., WEG‐REMERS, S., & PONTA, H. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06704.x · Cited by 166
Hyaluronic Acid (Ha) Binding to Cd44 Activates Rac1 and Induces Lamellipodia Outgrowth
Oliferenko, S., Kaverina, I., Small, J. V., & Huber, L. A. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.148.6.1159 · Cited by 165
PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling
Shrestha, Y., Schafer, E. J., Boehm, J. S., Thomas, S. R., He, F., Du, J., Wang, S., Barretina, J., Weir, B. A., Zhao, J. J., et al. (2012) · Oncogene · doi:10.1038/onc.2011.515 · Cited by 165
Functional inactivation of NF2/merlin in human mesothelioma
Thurneysen, C., Opitz, I., Kurtz, S., Weder, W., Stahel, R. A., & Felley‐Bosco, E. (2008) · Lung Cancer · doi:10.1016/j.lungcan.2008.08.014 · Cited by 162
Altomare, D. A., You, H., Xiao, G.-H., Ramos-Nino, M. E., Skele, K. L., De Rienzo, A., Jhanwar, S. C., Mossman, B. T., Kane, A. B., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1208744 · Cited by 158
A Mouse Model Recapitulating Molecular Features of Human Mesothelioma
Altomare, D. A., Vaslet, C. A., Skele, K. L., Rienzo, A. D., Devarajan, K., Jhanwar, S. C., McClatchey, A. I., Kane, A. B., & Testa, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2312 · Cited by 154
An anti-Ras function of neurofibromatosis type 2 gene product (NF2/Merlin).
Tikoo, A., Varga, M., Ramesh, V., Gusella, J. F., & Maruta, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31525-9 · Cited by 151
Lallemand, D., Manent, J., Couvelard, A., Watilliaux, A., Siena, M., Chareyre, F., Lampin-Saint-Amaux, A., Niwa‐Kawakita, M., Kalamarides, M., & Giovannini, M. (2008) · Oncogene · doi:10.1038/onc.2008.427 · Cited by 148
Alfthan, K., Heiska, L., Grönholm, M., Renkema, G. H., & Carpén, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313916200 · Cited by 142
Boggiano, J. C., & Fehon, R. G. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.03.013 · Cited by 142
Cd44 Enhances Neuregulin Signaling by Schwann Cells
Sherman, L. S., Rizvi, T. A., Karyala, S. V., & Ratner, N. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.1071 · Cited by 142
Regulation of the Hippo pathway by cell architecture and mechanical signals
Schroeder, M. C., & Halder, G. A. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.06.001 · Cited by 140
Occurrence and characterization of peripheral nerve involvement in neurofibromatosis type 2
Sperfeld, A. D., Hein, C., Schröder, J. M., et al. (2002) · Brain · doi:10.1093/brain/awf115 · Cited by 131
Shaw, R. J., McClatchey, A. I., & Jacks, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.13.7757 · Cited by 130
Neuregulin Signaling through a PI3K/Akt/Bad Pathway in Schwann Cell Survival
Li, Y., Tennekoon, G. I., Birnbaum, M. J., Marchionni, M. A., & Rutkowski, J. L. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0967 · Cited by 129
Pelton, P. D., Sherman, L. S., Rizvi, T. A., Marchionni, M. A., Wood, P. M., Friedman, R. A., & Ratner, N. (1998) · Oncogene · doi:10.1038/sj.onc.1202141 · Cited by 129
Ammoun, S., Flaiz, C., Ristic, N., Schuldt, J., & Hanemann, C. O. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5849 · Cited by 128
Kimura, Y., Koga, H., Araki, N., Mugita, N., Fujita, N., Takeshima, H., Nishi, T., Yamashima, T., Saido, T. C., Yamasaki, T., et al. (1998) · Nature Medicine · doi:10.1038/nm0898-915 · Cited by 122
Upregulation of the Rac1/JNK signaling pathway in primary human schwannoma cells
Kaempchen, K., Mielke, K., Utermark, T., Langmesser, S., & Hanemann, C. O. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg146 · Cited by 120
Mawrin, C., Sasse, T., Kirches, E., Kropf, S., Schneider, T. L., Grimm, C., Pambor, C., Vorwerk, C. K., Firsching, R. P., Lendeckel, U., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2550 · Cited by 118
The mammalian Hippo pathway: regulation and function of YAP1 and TAZ
Kodaka, M., & Hata, Y. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1742-9 · Cited by 117
Allison, K. H., & Sledge, G. W. (2014) · PubMed · Cited by 113
Regulation of mTOR Complex 2 Signaling in Neurofibromatosis 2–Deficient Target Cell Types
James, M. F., Stivison, E., Beauchamp, R. L., Han, S., Li, H., Wallace, M. R., Gusella, J. F., Stemmer-Rachamimov, A. O., & Ramesh, V. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0425-t · Cited by 112
Yokoyama, T., Osada, H., Murakami, H., Tatematsu, Y., Taniguchi, T., Kondo, Y., Yatabe, Y., Hasegawa, Y., Shimokata, K., Horio, Y., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn200 · Cited by 110
Grönholm, M., Sainio, M. A., Zhao, F., Heiska, L., Vaheri, A. I., & Carpén, O. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.6.895 · Cited by 109
Merlin Is a Potent Inhibitor of Glioma Growth
Lau, Y.-K. I., Murray, L. B., Houshmandi, S. S., Yin, X., Gutmann, D. H., & Yu, Q. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0190 · Cited by 107
ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma
Ammoun, S., Cunliffe, C. H., Allen, J. C., Chiriboga, L. A., Giancotti, F. G., Zagzag, D., Hanemann, C. O., & Karajannis, M. A. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq012 · Cited by 107
Zhou, L., Ercolano, E., Ammoun, S., Schmid, M. C., Barczyk, M., & Hanemann, C. O. (2011) · Neoplasia · doi:10.1593/neo.111060 · Cited by 105
Effect of merlin phosphorylation on neurofibromatosis 2 (NF2) gene function
Surace, E. I., Haipek, C. A., & Gutmann, D. H. (2004) · Oncogene · doi:10.1038/sj.onc.1207142 · Cited by 103
Bourguignon, L., Gilad, E., Peyrollier, K., Brightman, A., & Swanson, R. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04485.x · Cited by 103
Merlin: the neurofibromatosis 2 tumor suppressor
Gusella, J. F., Ramesh, V., MacCollin, M., & Jacoby, L. B. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00005-0 · Cited by 101
Fleury‐Feith, J., Boulangé-Lecomte, C., Renier, A., Matrat, M., Kheuang, L., Abramowski, V., Levy, F., Janin, A., Giovannini, M., & Jaurand, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206593 · Cited by 100
Nguyen, R., Reczek, D., & Bretscher, A. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006708200 · Cited by 99
Alternative splicing of the NF2 gene and its mutation analysis of breast and colorectal cancers
Arakawa, H., Hayashl, N., Nagase, H., Ogawa, M., & Nakamura, Y. (1994) · Human Molecular Genetics · doi:10.1093/hmg/3.4.565 · Cited by 99
Obremski, V. J., Hall, A., & Fernández‐Valle, C. (1998) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(199812)37:4<487::aid-neu1>3.0.co;2-b · Cited by 97
Self-citationBai, Y., Liu, Y.-J., Wang, H., Xu, Y., Stamenkovic, I., & Yu, Q. (2006) · Oncogene · doi:10.1038/sj.onc.1209849 · Cited by 96
Cheng, J. Q., Lee, W.-C., Klein, M. A., Cheng, G. Z., Jhanwar, S. C., & Testa, J. R. (1999) · Genes Chromosomes and Cancer · Cited by 96
mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma
Giovannini, M., Bonne, N.-X., Vitte, J., Chareyre, F., Tanaka, K., Adams, R., Fisher, L. M., Valeyrie‐Allanore, L., Wolkenstein, P., Goutagny, S., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not242 · Cited by 92
Axl/Gas6/NFκB signalling in schwannoma pathological proliferation, adhesion and survival
Ammoun, S., Provenzano, L., Zhou, L., Barczyk, M., Evans, K., Hilton, D. A., Hafizi, S., & Hanemann, C. O. (2013) · Oncogene · doi:10.1038/onc.2012.587 · Cited by 88
Stem cell regulation by the Hippo pathway
Hiemer, S. E., & Varelas, X. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.005 · Cited by 84
Kino, T., Takeshima, H., Nakao, M., Nishi, T., Yamamoto, K., Kimura, T., Saito, Y., Kochi, M., Kuratsu, J., Saya, H., et al. (2001) · Genes to Cells · doi:10.1046/j.1365-2443.2001.00432.x · Cited by 84
Houshmandi, S. S., Emnett, R. J., Giovannini, M., & Gutmann, D. H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01392-08 · Cited by 82
Malignant pleural mesothelioma
Pass, H. I., Vogelzang, N. J., Hahn, S. M., & Carbone, M. (2004) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2004.04.001 · Cited by 79
Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas
Lomas, J., Bello, M. J., Arjona, D., Alonso, M. E., Martínez‐Glez, V., Lopez-Marín, I., Amiñoso, C., de Campos, J. M., Isla, A., Vaquero, J., et al. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20141 · Cited by 76
Sher, I., Hanemann, C. O., Karplus, P. A., & Bretscher, A. P. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.03.008 · Cited by 75
The role of the Hippo pathway in human disease and tumorigenesis
Barron, D. A., & Kagey, J. D. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-25 · Cited by 70
A NHERF binding site links the βPDGFR to the cytoskeleton and regulates cell spreading and migration
James, M. F., Beauchamp, R. L., Manchanda, N., Kazlauskas, A., & Ramesh, V. (2004) · Journal of Cell Science · doi:10.1242/jcs.01156 · Cited by 70
Johnson, M. D., Okediji, E., Woodard, A., Toms, S. A., & Allen, G. S. (2002) · Journal of neurosurgery · doi:10.3171/jns.2002.97.3.0668 · Cited by 69
CpG island methylation in sporadic and neurofibromatis type 2-associated schwannomas
González‐Gómez, P., Bello, M. J., Alonso, M. E., Lomas, J., Arjona, D., de Campos, J. M., Vaquero, J., Isla, A., Lassaletta, L., Gutiérrez, M., et al. (2003) · PubMed · doi:10.5281/zenodo.10617916 · Cited by 67
Burns, S. S., Akhmametyeva, E. M., Oblinger, J. L., Bush, M. L., Huang, J., Senner, V., Chen, C., Jacob, A., Welling, D. B., & Chang, L. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1888 · Cited by 66
Merlin isoform 2 in neurofibromatosis type 2–associated polyneuropathy
Schulz, A., Baader, S. L., Niwa‐Kawakita, M., Jung, M. J., Bauer, R., Garcia, C. M., Zoch, A., Schacke, S., Hagel, C., Mautner, V., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3348 · Cited by 64
Pineau, P., Marchio, A., Nagamori, S., Seki, S., Tiollais, P., & Dejean, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50138 · Cited by 61
Laulajainen, M., Muranen, T. E., Carpén, O., & Grönholm, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210988 · Cited by 61
Lončarević, I., Roitzheim, B., Ritterbach, J., Viehmann, S. F., Borkhardt, A., Lampert, F. H., & Harbott, J. (1999) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199903)24:3<238::aid-gcc9>3.3.co;2-d · Cited by 61
Constitutive neuregulin‐1/ErbB signaling contributes to human vestibular schwannoma proliferation
Hansen, M. R., Roehm, P. C., Chatterjee, P., et al. (2006) · Glia · doi:10.1002/glia.20316 · Cited by 58
LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2
Petrilli, A., Copik, A. J., Posadas, M., Chang, L.-S., Welling, D. B., Giovannini, M., & Fernández‐Valle, C. (2013) · Oncogene · doi:10.1038/onc.2013.320 · Cited by 56
Self-citationNilotinib alone or in combination with selumetinib is a drug candidate for neurofibromatosis type 2
Ammoun, S., Schmid, M. C., Triner, J., Manley, P. W., & Hanemann, C. O. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor056 · Cited by 54
Cooper, J. M., Li, W., You, L., Schiavon, G., Pepe-Caprio, A., Zhou, L., Ishii, R., Giovannini, M., Hanemann, C. O., Long, S. B., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2002314 · Cited by 53
Temporal Control of Rac in Schwann Cell–Axon Interaction Is Disrupted inNF2-Mutant Schwannoma Cells
Nakai, Y., Zheng, Y., MacCollin, M., & Ratner, N. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.4865-05.2006 · Cited by 53
Agnihotri, S., Gugel, I., Remke, M., Bornemann, A., Pantazis, G., Mack, S. C., Shih, D. J. H., Singh, S. K., Sabha, N., Taylor, M. D., et al. (2014) · Journal of neurosurgery · doi:10.3171/2014.6.jns131433 · Cited by 45
Jacob, A., Oblinger, J. L., Bush, M. L., Brendel, V. J., Santarelli, G. D., Chaudhury, A. R., Kulp, S. K., Perle, K. M. D. L., Chen, C., Chang, L., et al. (2011) · The Laryngoscope · doi:10.1002/lary.22392 · Cited by 45
NCI-60 Whole Exome Sequencing and Pharmacological CellMiner Analyses
Reinhold, W. C., Varma, S., Sousa, F. G., Sunshine, M., Abaan, O. D., Davis, S. R., Reinhold, S. W., Kohn, K. W., Morris, J., Meltzer, P. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101670 · Cited by 45
Merlin Is a Negative Regulator of Human Melanoma Growth
Murray, L. B., Lau, Y.-K. I., & Yu, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043295 · Cited by 44
Microtubule-mediated transport of the tumor-suppressor protein Merlin and its mutants
Benseñor, L. B., Barlan, K., Rice, S. E., Fehon, R. G., & Gelfand, V. I. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907389107 · Cited by 42
Fluorescence Resonance Energy Transfer Analysis of Merlin Conformational Changes
Hennigan, R. F., Foster, L. A., Fedor‐Chaiken, M., Mani, T., Gomes, M. M., Herr, A. B., & Ip, W. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00248-09 · Cited by 41
Overexpression of ezrin inactivates NF2 tumor suppressor in glioblastoma
Morales, F. C., Molina, J. R., Hayashi, Y., & Georgescu, M. (2010) · Neuro-Oncology · doi:10.1093/neuonc/nop060 · Cited by 40
Schulz, A., Kyselyova, A. A., Baader, S. L., Jung, M. J., Zoch, A., Mautner, V., Hagel, C., & Morrison, H. (2013) · Brain · doi:10.1093/brain/awt327 · Cited by 38
Flaiz, C., Utermark, T., Parkinson, D. B., Poetsch, A., & Hanemann, C. O. (2008) · Glia · doi:10.1002/glia.20629 · Cited by 37
Inactivation of the NF2 tumor suppressor protein merlin in DU145 prostate cancer cells
Horiguchi, A., Zheng, R., Shen, R., & Nanus, D. M. (2008) · The Prostate · doi:10.1002/pros.20760 · Cited by 35
Boin, A., Couvelard, A., Couderc, C., Brito, I., Filipescu, D., Kalamarides, M., Bédossa, P., de Koning, L., Danelsky, C., Dubois, T., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou020 · Cited by 35
Petrilli, A. M., Fuse, M. A., Donnan, M. S., Bott, M., Sparrow, N. A., Tondera, D., Huffziger, J., Frenzel, C., Malany, C. S., Echeverri, C. J., et al. (2014) · Europe PMC (PubMed Central) · Cited by 34
Self-citationLaulajainen, M., Muranen, T. E., Nyman, T. A., Carpén, O., & Grönholm, M. (2011) · Neoplasia · doi:10.1593/neo.11356 · Cited by 31
Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor
Yogesha, S. D., Sharff, A., Giovannini, M., Bricogne, G., & Izard, T. (2011) · Protein Science · doi:10.1002/pro.751 · Cited by 31
Cell–Cell Junctions: α-Catenin and E-Cadherin Help Fence In Yap1
Robinson, B. S., & Moberg, K. H. (2011) · Current Biology · doi:10.1016/j.cub.2011.09.019 · Cited by 29
Thaxton, C., Lopera, J., Bott, M., Baldwin, M. E., Kalidas, P., & Fernández‐Valle, C. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2006.11.003 · Cited by 28
Self-citationA neuronal function of the tumor suppressor protein merlin
Schulz, A., Zoch, A., & Morrison, H. (2014) · Acta Neuropathologica Communications · doi:10.1186/preaccept-1812884552130941 · Cited by 27
Regulation of Son of sevenless by the membrane-actin linker protein ezrin
Geißler, K. J., Jung, M. J., Riecken, L. B., Sperka, T., Cui, Y., Schacke, S., Merkel, U., Markwart, R., Rubio, I., Than, M. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222078110 · Cited by 26
Khajeh, J. A., Ju, J. H., Atchiba, M., Allaire, M., Stanley, C. B., Heller, W. T., Callaway, D. J. E., & Bu, Z. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.05.011 · Cited by 26
The role of insulin‐like growth factors signaling in merlin‐deficient human schwannomas
Ammoun, S., Schmid, M. C., Ristic, N., Zhou, L., Hilton, D. A., Ercolano, E., Carroll, C., & Hanemann, C. O. (2012) · Glia · doi:10.1002/glia.22391 · Cited by 23
Yaegashi, S., Sachse, R., Ohuchi, N., Mori, S., & Sekiya, T. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03003.x · Cited by 22
Tumor Suppressor NF2/Merlin Is a Microtubule Stabilizer
Smole, Z., Thoma, C. R., Applegate, K. T., Duda, M., Gutbrodt, K. L., Danuser, G. M., & Krek, W. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1334 · Cited by 22
Mori, T., Gotoh, S., Shirakawa, M., & Hakoshima, T. (2014) · Genes to Cells · doi:10.1111/gtc.12161 · Cited by 21
Sabha, N. B., Au, K., Agnihotri, S., Singh, S. K., Mangat, R. K., Guha, A., & Zadeh, G. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039412 · Cited by 21
Malhotra, A., Shibata, Y., Hall, I. M., & Dutta, A. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25329 · Cited by 19
Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias
Yoo, N. J., Park, S. W., & Lee, S. H. (2011) · Pathology · doi:10.1097/pat.0b013e32834c3599 · Cited by 19
The p53/mouse double minute 2 homolog complex deregulation in merlin‐deficient tumours
Ammoun, S., Schmid, M. C., Zhou, L., Hilton, D. A., Barczyk, M., & Hanemann, C. O. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.08.005 · Cited by 18
Inhibition of SIRT2 in merlin/NF2-mutant Schwann cells triggers necrosis
Petrilli, A. M., Bott, M., & Fernández‐Valle, C. (2013) · Oncotarget · doi:10.18632/oncotarget.1422 · Cited by 17
Self-citationExpression of ErbB-1 and 2 in vestibular schwannomas
Wickremesekera, A., Hovens, C. M., & Kaye, A. H. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.05.009 · Cited by 14
Cited by
The Cancer Genome Atlas of renal cell carcinoma: findings and clinical implications
Linehan, W. M., & Ricketts, C. J. (2019) · Nature Reviews Urology · doi:10.1038/s41585-019-0211-5 · Cited by 621
Meningioma: A Review of Epidemiology, Pathology, Diagnosis, Treatment, and Future Directions
Ogasawara, C., Philbrick, B. D., & Adamson, D. C. (2021) · Biomedicines · doi:10.3390/biomedicines9030319 · Cited by 324
Negri, A., Naponelli, V., Rizzi, F., & Bettuzzi, S. (2018) · Nutrients · doi:10.3390/nu10121936 · Cited by 269
Tang, T. T., Konradi, A. W., Feng, Y., Peng, X., Ma, M., Li, J., Yu, F.-X., Guan, K.-L., & Post, L. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0717 · Cited by 245
Insights into recent findings and clinical application of YAP and TAZ in cancer
Franklin, J. M., Wu, Z., & Guan, K.-L. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-023-00579-1 · Cited by 213
Metadata
- Authors
- Petrilli, A. M., & Fernández-Valle, C.
- Venue
- Oncogene
- Published
- 2015-04-20
- Volume
- 35
- Issue
- 5
- Pages
- 537-548
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2108745864
- Cited by
- 458
- References
- 152
- FWCI
- 16.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.